Cumberland Pharmaceuticals CPIX Gain (Loss) on Investments

Gain (Loss) on Investments at other companies

James River Group Holdings, Inc. JRVR

-$548.75K+68.6%

ASI

Ategrity Specialty Insurance Company HoldingsASIC

$3.16M-54.8%

Cavco IndustriesCVCO

$1.05M—

Arthur J. GallagherAJG

-$2M-133%

Dominion EnergyD

-$162M-39.7%

Cadence Design SystemsCDNS

$13.93M+877%

Other financials

Income statement

See full

Revenue$9.1M-22.0%

Gross profit$7.2M-30.0%

Operating income-$3.1M-342%

Net income-$3.3M-362%

EPS (diluted)-$0.22-375%

Balance sheet

See full

Cash & equivalents$11.0M-27.1%

Total debt$4.8M-7.1%

Total equity$21.6M-24.5%

Total assets$71.0M+1.5%

Cash flow

See full

Operating cash flow$387.0K-90.1%

CapEx--100%

Free cash flow$387.0K-89.9%

Valuation

See full

Market cap$97.09M+138%

Enterprise value$90.91M+207%

P/S2.3×+1.3×

Profitability

See full

Gross margin82.9%-1.4pp

Operating margin-17.2%-125pp

Net margin-17.6%-103pp

FCF margin3.3%—

Returns & leverage

See full

Return on equity-29.4%-86.3pp

Debt / equity0.2×0.0×

Current ratio1×-0.3×

Where this comes from

Reported directly by Cumberland Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:GainLossOnInvestments.

The official record: Cumberland Pharmaceuticals’s 10-K, filed March 9, 2026, on SEC EDGAR. View the filing →

Ask your AI about Cumberland Pharmaceuticals's gain (loss) on investments.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Cumberland Pharmaceuticals's gain (loss) on investments?: Cumberland Pharmaceuticals (CPIX) reported gain (loss) on investments of -$3.31K in Q4 2025.